Genevieve Meier
0000-0003-1228-6969
Publication & Citation Trends
Publications
0 total
Disease landscape of advanced HER2-breast cancer patients by treatment line in three EU countries and USA OA
Cited by 2
Semantic Scholar
Re-examining the factor structure of the Insomnia Severity Index (ISI) and defining the meaningful within-individual change (MWIC) for subjects with insomnia disorder in two phase III clinical trials of the efficacy of lemborexant OA
Cited by 2
Semantic Scholar
Insomnia treatments and on-the-road driving performance: a systematic literature review (4601)
Cited by 0
Semantic Scholar
Comparison of the effect of lemborexant and other insomnia treatments on driving performance: a systematic review and meta-analysis OA
Cited by 6
Semantic Scholar
Comparative efficacy of lemborexant and other insomnia treatments: a network meta-analysis OA
Cited by 35
Semantic Scholar
338 How Much Improvement in the Insomnia Severity Index Is Associated With a Positive Impact of A Patient’s Insomnia Medication? OA
Cited by 0
Semantic Scholar
Health-related quality of life in pediatric patients with partial onset seizures or primary generalized tonic-clonic seizures receiving adjunctive perampanel.
Cited by 9
Semantic Scholar
Research Topics
Influenza Virus Research Studies
(34)
Respiratory viral infections research
(21)
Hepatocellular Carcinoma Treatment and Prognosis
(13)
CAR-T cell therapy research
(13)
COVID-19 epidemiological studies
(8)
Affiliations
AstraZeneca (United Kingdom)
GlaxoSmithKline (United Kingdom)
GlaxoSmithKline (Belgium)
GlaxoSmithKline (United States)
AstraZeneca (Brazil)